HARTFORD INSURANCE GROUP, INC.·4

Feb 26, 4:06 PM ET

Costello Beth Ann 4

4 · HARTFORD INSURANCE GROUP, INC. · Filed Feb 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Hartford (HIG) CFO Beth Ann Costello Receives 22,051 Option Award

What Happened

  • Beth Ann Costello, EVP and Chief Financial Officer of Hartford Insurance Group (HIG), was granted 22,051 derivative securities reported as an award (Form 4 code A) on 2026-02-24. The filing shows an acquisition price of $0.00 (this indicates a compensation award rather than a market purchase); total value is reported as $0 in the excerpt. Footnote F1 identifies these awards as stock options with a three‑year vesting schedule.

Key Details

  • Transaction date: 2026-02-24; Form 4 filed: 2026-02-26 (filed on time; not marked late).
  • Transaction type/code: Grant/Award of derivative securities (A).
  • Quantity and price: 22,051 options; reported acquisition price $0.00 (grant).
  • Vesting (per footnote F1): one‑third exercisable on 02/24/2027, one‑third on 02/24/2028, and the remainder on 02/24/2029 (fully vested by 3rd anniversary).
  • Exercise price/market value: Not specified in the provided excerpt (the $0 in the filing reflects the grant; exercise price may be disclosed elsewhere).
  • Shares owned after transaction: Not specified in the provided excerpt.
  • Additional notes: The filing includes several footnotes (F2–F9) listing vesting/exercise dates for prior option grants.

Context

  • This was a compensation grant of options (a derivative award), not a cash purchase or sale. Grants do not require an immediate cash outlay by the insider and are a routine part of executive compensation; they do not by themselves signal buying or selling by the insider.
  • Future Form 4 filings would report any exercises or sales of these options or underlying shares. If you want exercise price or full award terms, check the company’s proxy statement or the full Form 4 filing for complete details.

Insider Transaction Report

Form 4
Period: 2026-02-24
Transactions
  • Award

    Stock Option

    [F1]
    2026-02-24+22,05122,051 total
    Exercise: $140.54Exp: 2036-02-24Common Stock (22,051 underlying)
Holdings
  • Common Stock

    92,988.282
  • Stock Option

    [F2]
    Exercise: $49.01Exp: 2029-02-26Common Stock (75,790 underlying)
    75,790
  • Stock Option

    [F3]
    Exercise: $51.87Exp: 2031-02-23Common Stock (67,204 underlying)
    67,204
  • Stock Option

    [F4]
    Exercise: $53.81Exp: 2028-02-27Common Stock (63,194 underlying)
    63,194
  • Stock Option

    [F5]
    Exercise: $55.27Exp: 2030-02-25Common Stock (71,318 underlying)
    71,318
  • Stock Option

    [F6]
    Exercise: $69.41Exp: 2032-02-23Common Stock (75,483 underlying)
    75,483
  • Stock Option

    [F7]
    Exercise: $78.28Exp: 2033-02-28Common Stock (57,492 underlying)
    57,492
  • Stock Option

    [F8]
    Exercise: $95.74Exp: 2034-02-27Common Stock (25,223 underlying)
    25,223
  • Stock Option

    [F9]
    Exercise: $116.41Exp: 2035-02-25Common Stock (21,847 underlying)
    21,847
Footnotes (9)
  • [F1]One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.
  • [F2]The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
  • [F3]The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
  • [F4]The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
  • [F5]The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
  • [F6]The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
  • [F7]One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
  • [F8]One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
  • [F9]One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
Signature
Anthony J. Salerno, Jr., Attorney-in-Fact|2026-02-26

Documents

1 file
  • 4
    doc4.xmlPrimary